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Background: Febrile illness is the commonest cause of hospitalization in children
<5 years in sub-Saharan Africa, and bacterial bloodstream infections and malaria are
major causes of death.
Methods: From March 2017 to July 2018, we enrolled 2,226 children aged 0–5 years
hospitalized due to fever in four major public hospitals of Dar es Salaam, namely, Amana,
Temeke, and Mwananyamala Regional Hospitals and Muhimbili National Hospital. We
recorded social demographic and clinical data, and we performed blood-culture and
HIV-antibody testing. We used qPCR to quantify Plasmodium falciparum parasitaemia
and Matrix-Assisted Laser Desorption/Ionization-Time of Flight (MALDI-TOF) to identify
bacterial isolates. Disk diffusion method was used for antimicrobial susceptibility testing.
Results: Nineteen percent of the children (426/2,226) had pathogens detected from
blood. Eleven percent (236/2,226) of the children had bacteraemia/fungaemia and
10% (204/2,063) had P. falciparum malaria. Ten children had concomitant malaria
and bacteraemia. Gram-negative bacteria (64%) were more frequent than Gram-
positive (32%) and fungi (4%). Over 50% of Gram-negative bacteria were extended-
spectrum beta-lactamase (ESBL) producers and multidrug resistant. Methicillin resistant
Staphylococcus aureus (MRSA) was found in 11/42 (26.2%). The most severe form
of clinical malaria was associated with high parasitaemia (>four million genomes/µL)
of P. falciparum in plasma. Overall, in-hospital death was 4% (89/2,146), and it was
higher in children with bacteraemia (8%, 18/227) than malaria (2%, 4/194, p = 0.007).
Risk factors for death were bacteraemia (p = 0.03), unconsciousness at admission
(p < 0.001), and admission at a tertiary hospital (p = 0.003).
Conclusion: Compared to previous studies in this region, our study showed a
reduction in malaria prevalence, a decrease in in-hospital mortality, and an increase
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in antimicrobial resistance (AMR) including ESBLs and multidrug resistance. An increase
of AMR highlights the importance of continued strengthening of diagnostic capability
and antimicrobial stewardship programs. We also found malaria and bacteraemia
contributed equally in causing febrile illness, but bacteraemia caused higher in-
hospital death. The most severe form of clinical malaria was associated with
P. falciparum parasitaemia.
Keywords: bacteraemia, malaria, antimicrobial resistance, P. falciparum, Tanzania
INTRODUCTION
Bloodstream infections (BSI) are the commonest causes of
hospital admissions and deaths in children in sub-Saharan Africa
(Bahwere et al., 2001; Campbell et al., 2004; Peters et al., 2004;
Bryce et al., 2005; Feikin et al., 2011; Maze et al., 2018). Severe
BSI due to bacteria and malaria parasites are often difficult to
differentiate clinically (Evans et al., 2004) especially where semi-
immune children may have malaria parasites in their blood
without clinical disease. Therefore, to guide management of these
patients, a more specific test that can identify level of parasitemia
and support the clinical differentiation between severe malaria,
malaria causing disease, and subclinical malaria controlled by
immunity is important. A recent study (Imwong et al., 2015)
has shown that plasma qPCR can play a role in detecting
and differentiating severe malaria from non-severe malaria by
quantifying Plasmodium falciparum in plasma samples.
Recent efforts in scaling up malaria control programs such
as increased use and availability of rapid diagnostic tests (RDT),
distribution of free insecticide-treated bed nets, and change
to more effective malaria treatment guidelines in sub-Saharan
Africa have resulted in a substantial decline of malaria-associated
morbidity and mortality (O’Meara et al., 2010; Smithson et al.,
2015; Hershey et al., 2017; Kayentao et al., 2018).
Determining bacterial or fungal infections in BSI is
fundamental to management of severe BSI based on etiology. This
is challenging in low-income countries because easily available
and affordable diagnostic services for BSI other than malaria is
limited by both infrastructure and cost (Archibald and Reller,
2001; Petti et al., 2006). As a result, clinicians in low-income
countries lack information on local causes of severe BSI and rely
on empirical treatment guided by WHO Integrated Management
of Childhood Illnesses (IMCI) guidelines. Although IMCI is
useful, it may underestimate or overestimate the likelihood of
certain causes of disease, risking poor clinical outcomes and the
promotion of antimicrobial resistance. Appropriate management
of severe BSI in children is also required to minimize the spread
of antimicrobial resistance (AMR).
Microbial etiology of febrile illness varies from bacteria,
viruses, parasites, or fungi, between children attending outpatient
health care facilities versus in hospitals (Maze et al., 2018),
and geographically (Maze et al., 2018; Moreira et al., 2018;
Shrestha et al., 2018).
In the Dar es Salaam region of Tanzania, a previous study
reported causes of febrile illness among children attending out-
patient clinics only (D’Acremont et al., 2014). Three other studies
were conducted in a single tertiary referral hospital, Muhimbili
National Hospital, two of which focused solely on neonatal sepsis
(Blomberg et al., 2005; Mhada et al., 2012; Mkony et al., 2014).
None of these studies used plasma qPCR to detect and quantify
P. falciparum malaria.
With the reduction of malaria in mind, information is
required, first on the current causes of severe febrile illness
and death among hospitalized children, second on the role of
P. falciparum qPCR to quantify parasitaemia and differentiate
severe from non-severe clinical malaria, and lastly, the current
status of antimicrobial resistance. The present study provides
updated information on the contribution of bacteria, fungi,
and malaria in severe febrile illness among children admitted
in four major hospitals of Dar es Salaam, Tanzania. We
also report the risk factors for in-hospital death. In addition,
the study shows the association of clinical malaria severity
and the levels of P. falciparum parasitemia, using plasma
qPCR. We hypothesized that there is widespread antimicrobial
resistance in pathogens causing BSI. Our findings showed that
there is an increase in the rate of antimicrobial resistance,
extended spectrum beta-lactamases, and multidrug resistance.
The information will increase clinical awareness of the emerging
public health problem of AMR.
MATERIALS AND METHODS
Study Sites and Population
This hospital-based cross-sectional study was conducted from
March 2017 to July 2018 in Dar es Salaam, Tanzania. The
study consecutively included children aged ≤5 years who
were hospitalized because of fever (≥37.5◦C) at three regional
hospitals, Amana, Temeke, and Mwananyamala, and a tertiary
hospital, Muhimbili National Hospital (MNH). These are the
main public hospitals that serve approximately five million
people living in the Dar es Salaam region. The entry point of
the study was admission of the patient, and the end point was
at discharge of the patient from the hospital, referral to other
facilities, and death.
Collection of Demographic and Clinical
Information
Parents/caretakers of study participants, who consented to
participate in the study, were interviewed, and demographic
information was gathered using the electronic case report
form (eCRF) REDCap. Information recorded were date of
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birth, sex of the child, duration of fever, history and duration
of convulsions, vomiting, cough, diarrhea and its duration,
antibiotic use during 1 month before the current admission,
and history of hospital admissions during the last 6 months.
The attending physician performed clinical examination and
recorded the following information: level of consciousness, pulse
rate, respiratory rate, neck stiffness, irritability, and jaundice.
Hemoglobin level was recorded when available. Information
was recorded on any antibiotic or antimalarial prescribed by
the attending physician, and whether the child had received
antibiotics or antimalarials before blood culture was taken.
Outcome was recorded as discharged, transferred to another
hospital, or died.
Specimen Collection and Processing
A total of 1–5 mL of blood was collected from each child
within 24 h of admission. 1–2 mL of blood was inoculated in a
pediatric blood culture bottle and incubated at 35◦C using the
BACTEC 9050 R© (Becton–Dickinson, Sparks, MD, United States)
culture system for a maximum of 5 days unless flagged positive
earlier. The remaining blood was aliquoted, one portion of whole
blood was added to Tempus blood RNA tubes (Thermo Fisher
Scientific, Waltham, MA, United States), and the rest if any was
centrifuged at 3,000 rpm for 10 min at 4◦C to obtain plasma
and stored at −80◦C until further analysis. Blood remaining
after aliquoting was used for HIV rapid testing as per national
rapid HIV testing algorithm, SD bioline HIV-1/2 3.0 (Standard
Diagnostics Inc., South Korea) followed by Uni-GoldTM HIV
(Trinity Biotech Manufacturing Ltd., Bray, Ireland).
Detection and Identification of Bacteria
and Fungi
Positive blood cultures were sub-cultured on sheep-blood,
MacConkey, chocolate, and Sabouraud Dextrose agar (SDA)
plates. Standard microbiological methods such as conventional
biochemical tests and analytical profile index (API) (bioMérieux
SA, Marcy l’Etoile, France) were used for identifying bacterial
isolates. Fungal isolates that grew on SDA were Gram stained, and
for yeast cells germ-tube test was performed. Final identification
of both bacterial and fungal isolates was done with MALDI-TOF
MS using the Microflex LT instrument and MALDI Biotyper 3.1
software (Bruker Daltonics, Bremen, Germany).
Antimicrobial Susceptibility Testing
Antimicrobial susceptibility testing was done by disk diffusion
technique according to guidelines and breakpoints of the Clinical
Laboratory Standards Institute (CLSI; CLSI, 2019). Isolates
showing intermediate susceptibility were categorized as resistant.
Screening of ESBL phenotype was performed using cefotaxime
and ceftazidime disk, and those with reduced susceptibility
were confirmed with the BBL Sensi-Disc ESBL Confirmatory
Test Disks (Becton Dickinson, Sparks, MD, United States).
Screening for MRSA was done using cefoxitin disk, and resistant
Staphylococcus aureus isolates were confirmed by the presence
of mecA using PCR as previously described (Moyo et al.,
2014). Screening and confirmation of vancomycin resistance
for S. aureus and Enterococcus spp. was done using E-test
(bioMérieux). Quality control strains were included for all
screening tests and PCR.
Extraction of Total Nucleic Acid (TNA)
Pathogen Universal Kits (Roche Diagnostics) for total nucleic
acid (TNA) were used for extraction of both DNA and RNA
from plasma and whole blood, on MagNA Pure 96 instrument
(Roche Diagnostics GmbH, Mannheim, Germany). Input volume
of plasma and/whole blood was 500 µL, extracted TNA (100 µL)
was stored at−80◦C.
Detection of Malaria and Parasite
Quantification
Plasmodium falciparum was detected and quantified using qPCR.
The target used for detection of P. falciparum was varATS, using
primers, probes, and conditions described previously (Hofmann
et al., 2015). Master mix with primers and probes dispensed
on a 384 plate was provided by Eurogentec (Eurogentec, Liège,
Belgium). Briefly a total reaction volume of 13.3 µL was used,
of which master mix was 9.3 µL of TakyonTM Master Mix
(Eurogentec, Liège, Belgium) and template volume was 4 µL.
The final concentration of primer and probe were 800 and
400 nM, respectively. PCR was done using the Light Cycler
480 II Instrument (Roche Diagnostics, Mannheim, Germany).
Each run included a positive control and multiple no-template
controls. A plasmid with synthetic varATS insert was included
(Blue Heron Biotech, Bothell, WA, United States) for PCR and
for quantification. DNA quantity for samples with P. falciparum
DNA less than the Limit of Quantification (LOQ) was set to be
equal to or less than the LOQ (estimated to ≤0.05 genomes/µL).
The efficiency (using the formula E = 10−1/slope − 1) was 91.2%,
and error value (E) of the assay was 0.012.
Statistical Analysis
Data collected and entered in REDCap was exported to Statistical
Package for Social Sciences (SPSS) version 24.0, which was
used for data analysis. Categorical data were displayed using
frequencies and percentages, and continuous data were displayed
using the mean/median and interquartile range (IQR). Chi square
and Fischer’s exact test were used to determine association
between categorical variables. The risk factors for in-hospital
mortality, associations between bacteraemia/malaria, and the
demographic/clinical variables were analyzed using univariable
and multivariable logistic regression analyses controlling for age
and gender of the children. Association between P. falciparum
malaria parasitaemia by qPCR and clinical malaria severity scores
was assessed by ANOVA. For all analyses, a P-value of<0.05 was
considered statistically significant.
RESULTS
The Study Population
The study included 2,226 children under 5 years of age. Of
these 1,299 (58%) were males. The majority of children were
below 2 years of age (1,821/2,226, 82%). The mean and median
age were 11.09 and 2.04 months, respectively. Figure 1 shows
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the distribution of study participants from the different study
sites. Temeke Regional Referral Hospital accounted for many
participants, 948/2,226 (43%), followed by Amana Regional
Referral Hospital, 796/2,226 (36%).
HIV test results were available for 1,169/2,226 (53%), and 4%
(40/1,169) tested positive for HIV. Symptoms among patients
with malaria and bacteraemia are shown in Supplementary
Table 1.
Of the 2,226 children admitted with fever, 33.6% (747/2,226)
had symptoms representing specific syndromes as follows:
gastroenteritis (diarrhea 10.9% [243/2,226]); meningitis/neck
stiffness, 2.7% (59/2,226); and respiratory tract infection/cough,
20.0% (445/2,226).
Prevalence of Bacteria, Fungi, and
P. falciparum in Blood
At least one pathogen was detected in blood from 19%
(426/2,226) of the patients. A total of 243 bacteria and fungi
were isolated from 236/2,226 children (11%) (Figure 1). The
majority of pathogens isolated were Gram-negative bacteria
(GNB), (n = 156, 64%), followed by Gram-positive bacteria (GPB)
(n = 78, 32%) and fungi (n = 9, 4%). Figure 2 shows distribution
of bacteria and fungi isolated.
Gram-negative bacteria isolated were Klebsiella pneumoniae
(42%), Escherichia coli (19%), Pseudomonas spp. (8%),
Acinetobacter spp. (8%), Salmonella spp. (6%), Serratia
marcescens (5%), Enterobacter cloacae (5%), Alcaligenes
faecalis (3%), Pantoea and Providencia spp. (3%), other
Gram-negative bacteria (6/156, 3.85%) were Proteus mirabilis
(n = 2), Brevundimonas diminuta (n = 1), Ralstonia pickettii
(n = 1), Microbacterium aurum (n = 1), and Ochrobactrum tritici
(n = 1).
Gram-negative bacteria isolated were S. aureus
(54%), E. faecalis (15%), Enterococcus faecium (23%),
S. pneumoniae (4%), and Streptococcus agalactiae (3%) and
Enterococcus avium (1%).
Fungi isolated were Candida parapsilosis (56%), Candida
albicans (22%), and Wickerhamomyces anomalus (22%). In this
study we performed single blood culture, therefore we could not
confirm coagulase negative Staphylococcus as a cause of the blood
stream infection. Coagulase-negative Staphylococcus, Bacillus,
and Micrococcus spp. were regarded as likely contaminants and
excluded from analysis. These contaminants were found in
4.1% (92/2,226).
Plasma and whole blood samples were available for 1,811
and 252 children, respectively, and total nucleic acid (TNA)
was extracted from these 2,063 children. The prevalence of
P. falciparum malaria was 10% (204/2,063).
Malaria Severity by Clinical Criteria and
qPCR of P. falciparum From Plasma
To categorize severe and non-severe malaria we used the presence
of one or more of the following severity criteria following
World Health Organization (WHO) guidelines (World Health
Organization [WHO], 2014): jaundice, high respiratory rate as
defined by WHO, convulsions, unconsciousness with Blantyre
FIGURE 1 | The distribution of the study population. *Sample size for malaria (N = 1988); AB, antibiotic treatment received on admission, AM, antimalaria treatment
received on admission.
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FIGURE 2 | Pathogens isolated from blood culture. Other Gram-negative bacteria include two Proteus mirabilis and one of each of the following; Brevundimonas
diminuta, Ralstonia pickettii, Microbacterium aurum, and Ochrobactrum tritici.
TABLE 1 | The quantity (median value) of Plasmodium falciparum in plasma in genomes/µL for the four groups and children who died in each group, and P-value for
each group compared with group 3.
Malaria severity score N Number of deaths Quantity of P. falciparum genomes/µL (range) P-value
Group 0 94 0 7.56 × 105 (0.46 × 100–1.77 × 107) 0.01
Non-severe malaria
Group 1 61 0 5.77 × 105 (0.27 × 100–7.78 × 106) 0.008
Severe malaria with 1 criterium
Group 2 34 1 9.08 × 105 (1.40 × 100–2.53 × 107) 0.041
Severe malaria with 2 criteria
Group 3 15 3 4.07 × 106 (1.02 × 101–37.2 × 107) –
Severe malaria with 3 or more criteria
Coma Scale < 3, and anemia with hemoglobin < 5 g/dL. Deaths
and parasite quantity among children categorized with increasing
number of severity scores, divided in four groups, are shown
in Table 1. The median quantity of P. falciparum in plasma
measured by qPCR (expressed as genomes/µL) was significantly
higher in children with 3 or more severity criteria compared to
the other groups.
Bacteria and Malaria Co-infection
Among children with malaria, 5% (10/204) had co-infection with
bacteraemia. Bacteria isolated among these children were Serratia
marcescens (n = 2), K. pneumoniae (n = 2), and one of each of
the following bacteria: E. coli, Acinetobacter ursingii, Alcaligenes
faecalis, Ochrobactrum tritici, E. faecium, and S. aureus. Of the
10 children with bacteria-malaria co-infection, 40% (4/10) had
clinically severe disease and high malaria parasitaemia by qPCR,
and one of these four children died.
Treatment Received on Admission
Of 2,226 children included, 10% (216/2,226) received anti-
malarial treatment and 79% (1752/2,226) antibiotic treatment on
admission, before blood culture was taken (Figure 1). Of 200
children who were treated with anti-malarials, 50% (100/200)
had malaria positive qPCR results. Among malaria qPCR positive
children, as many as 51% (104/204) did not receive antimalarials
at admission. Of those who received antibiotics, only 12%
(201/1,752) had a positive blood culture. Among children
with bacteraemia, 15% (35/236) did not receive antibiotic on
admission (Figure 1).
Association Between
Malaria/Bacteraemia and
Demographic/Clinical Characteristics
Table 2 summarizes associations between malaria or
bacteraemia/fungaemia and social demographic or clinical
characteristics in multivariable logistic regression model
analyses. The prevalence of bacteria and fungi was highest
(14%) in children below the age of 3 months (P-value < 0.001,
OR 2.81, 95%CI 1.73–4.58). The median age for malaria
infection was 27 months. Malaria prevalence was significantly
increasing with age, with the highest prevalence (31%) among
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TABLE 2 | Multivariable analyses of bacteraemia/fungaemia and malaria and social demographic/clinical characteristics of children admitted with fever from March 2017
to July 2018 in Dar es Salaam, Tanzania.
Demographic/clinical characteristics Malaria (n = 2063) Bacteraemia/fungaemia (n = 2,226)
N n (%) P-value; OR (95% CI) N n (%) P-value; OR (95% CI)
Age in months
0–3 1115 31 (2.8) 1 1214 172 (14.2) <0.001; 2.75 (1.72–4.40)
4–6 111 10 (9.0) 0.001; 3.49 (1.65–7.35) 122 10 (8.2) 0.35; 1.45 (0.66–3.16)
7–11 212 15 (7.1) 0.004; 2.58 (1.36–4.89) 220 12 (5.5) 0.84; 0.93 (0.45–1.92)
12–24 285 39 (13.7) <0.001; 5.43 (3.30–8.92) 304 20 (6.6) 0.69; 1.14 (0.61–2.13)
≥25 376 116 (30.9) 0.001; 15.27 (9.92–23.49) 366 22 (6.0) 1
Sex
Male 1205 127 (10.5) 0.30; 0.84 (0.61–1.16) 1299 143 (11.0) 0.34; 0.87 (0.66–1.15)
Female 858 77 (9.0) 1 927 93 (10.0) 1
Consciousness
Unconscious 119 32 (26.9) 0.004; 2.19 (1.29–3.71) 136 18 (13.2) 0.09; 1.69 (0.92–3.10)
Awake 1944 172 (8.8) 1 2090 218 (10.4) 1
Convulsions
Yes 307 54 (17.6) 0.63; 1.11 (0.73–1.66) 339 35 (10.3) 0.95; 1.02 (0.65–1.59)
No 1756 150 (8.5) 1 1887 201 (10.7) 1
Jaundice
Yes 59 10 (16.9) 0.12; 1.87 (0.85–4.14) 63 8 (12.7) 0.98; 0.99 (0.45–2.18)
No 2004 194 (9.7) 1 2163 228 (10.5) 1
OR, odds ratio; CI, confidence interval; Confidence intervals that do not overlap the null value of OR = 1 are shown in bold.
children older than 25 months (P-value < 0.001, OR 20.04,
95% CI 12.72–31.58). Unconsciousness was also associated with
malaria with P value 0.03, OR 1.83, and 95% CI (1.07–3.13).
In univariable analysis, severe anemia, convulsions, reduced
consciousness, and vomiting were associated with malaria, as
shown in Supplementary Table 1.
In-Hospital Death and Risk Factors
Outcome data were available for 2,146 and 1,988 children tested
for bacteraemia/fungaemia and malaria qPCR, respectively. Of
2,146 children, 89 (4%) died while 2,057 (96%) improved and
were discharged from the hospital. Of children who died, 25%
(22/89) had pathogens detected in blood; 18 had bacteria/fungi
and four had P. falciparum. Outcome was not known for 80
children (4%); 58 were referred to a different hospital because
their condition worsened, while for 22 children information was
not recorded. Table 3 summarizes risk factors for in-hospital
mortality in the multivariable regression analyses. Mortality
varied at different study sites, with MNH showing higher
mortality compared to the rest of the study sites. Independent
risks of death in multivariable analysis were admission at a
tertiary hospital (MNH), bacteraemia, and unconsciousness on
admission. In the univariable analysis, in-hospital death was
significantly higher among HIV-infected children 6/37 (16.2%)
vs. non-HIV-infected children 71/1,919 (3.7%), P-value 0.003;
OR 3.68, 95% CI (1.47–9.21).
Four children with malaria died. All had severe malaria
according to clinical criteria, and in addition high parasitaemia
of >1.6 million P. falciparum genomes/µL (Table 1). All
were unconscious on admission. One was co-infected with
K. pneumoniae. All four were HIV negative. Three of the children
were treated with artesunate, while the child with bacterial co-
infection did not receive anti-malarial treatment.
Among the 18 children who died and had bacteraemia,
7/18 (39%), 4/18 (22%), and 2/18 (11%) were infected with
K. pneumoniae, E. coli, and S. aureus, respectively. Additionally,
two children were infected with Pseudomonas spp., one with
Acinetobacter baumannii, one with S. marcescens, and one with
Streptococcus pneumoniae.
Of the 18 children who died, 16 (88%) received antibiotic
treatment. Antibiotics prescribed to these children were a
combination of either amoxycillin/clavulanic acid or ceftriaxone
and gentamicin. Susceptibility testing showed most Gram-
negative bacteria were ESBL producers and multi drug
resistant (MDR).
Antimicrobial Resistance Pattern for
Bacteria Isolated From Blood Cultures
Antimicrobial resistance pattern among Gram-negative bacteria
(GNB) and Gram-positive bacteria (GPB) is shown in Table 4.
GNBdisplayed high rates of resistance to commonly used
antimicrobials. Extended-spectrum beta-lactamase (ESBL)
phenotype was observed in 51% of the GNB. K. pneumoniae
displayed the highest rate of ESBL (90%) followed by E. coli
(36%) and other Gram-negative bacteria (14%). Multidrug
resistance (MDR), defined as resistance to three or more classes
of antimicrobials, was also high (54%) among GNB. MDR
among K. pneumoniae, E. coli, and Acinetobacter spp. were
90.3, 36, and 40%, respectively. Gentamicin resistance among
GNB was found in 49%. One third of GNB were resistant to
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TABLE 4 | Antimicrobial resistance pattern for Gram-negative and Gram-positive bacteria isolated from children admitted with fever from March 2017 to July 2018 in Dar
es Salaam, Tanzania.
Antimicrobial agent Gram-negative bacteria Gram-positive bacteria
K. pneumoniae E. coli Acinetobacter spp. Pseudomonas spp. Others* Total S. aureus Enterococcus spp.
n = 62 n = 28 n = 10 n = 12 n = 22 n = 134 n = 42 n = 30
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
PN NT NT NT NT NT NT 40 (95.2%) 17 (56.7%)
AMC NT NT NT NT NT NT 0 17 (56.7%)
AMP NT NT NT NT NT NT NT 18 (60.0%)
CIP 27 (43.5) 11 (39.3) 2 (20.0) 2 (16.7) 2 (9) 44 (32.83) 10 (23.8%) 21 (70.0%)
TZP 40 (64.5) 0 (0.0) 4 (40.0) 0 0 44 (32.83) NT NT
TGC 22 (35.5) 1 (3.6) NT NT 3 (13.6) 26 (21.31) NT 0
FOX 1 (1.6) 2 (7.1) NT NT 3 (13.6) 5 (4.09) 11 (26.2%) NT
ATM 50 (80.6) 10 (35.7) NT 1 (8.3) 2 (9) 63 (50.81) NT NT
CAZ 56 (90.3) 10 (35.7) 5 (50.0) 0 2 (9) 73 (54.5) NT NT
CTX 56 (90.3) 10 (35.7) 10 (100) NT 2 (9) 78 (58.2) 11 (26.2%) NT
SXT 57 (91.9) 22 (78.6) 4 (40.0) NT 7 (31.8) 90 (73.77) 1 (2.4%) NT
CN 53 (85.5) 7 (25.6) 4 (40.0) 1 (8.3) 1 (84.5) 66 (49.25) 14 (33.3%) NT
C 14 (22.6) 4 (14.3) NT NT 2 (9) 20 (17.86) 4 (9.5%) 6 (20.0%)
DO 25 (40.3) 0 (0.0) 0 NT 4 (18) 29 (7.38) 10 (23.8%) 10 (33.3%)
LIN NT NT NT NT NT NT NT 5 (16.7%)
MEM 0 (0.0) 0 (0.0) 2 (20.0) 2 (16.7) 0 4 (2.98) 7 (16.7%) NT
VAN NT NT NT NT NT NT 0 (0.0) 0 (0.0)
Others* = Salmonella typhi and Salmonella spp., E. cloacae and Serratia spp.; PN, penicillin; AMC, amoxicillin/clavulanic acid; AMP, ampicillin; CIP, ciprofloxacin; TZP,
piperacillin/tazobactam; TGC, tigecycline; FOX, cefoxitin; ATM, aztreonam; CAZ, ceftazidime; CTX, cefotaxime; SXT, sulfamethoxazole/trimethoprim; CN, gentamicin; C,
chloramphenicol; DO, doxycycline; MEM, meropenem; LIN, linezolid; VAN, vancomycin; NT, not tested.
ciprofloxacin, and the highest resistance rate(44%) was among
K. pneumoniae. Resistance to meropenem was observed in the
following isolates of A. baumannii (n = 2) and two isolates
of Pseudomonas spp. (n = 2). Like GNB, GPB also displayed
high rates of resistance toward different antimicrobial agents.
For S. aureus, the prevalence of Methicillin resistant S. aureus
(MRSA) was 26%, and MDR was seen in one third of isolates.
Enterococcus spp. showed a high rate of MDR of over 80%. There
was no vancomycin resistance detected among S. aureus and
Enterococcus spp.
DISCUSSION
In an African setting, identifying etiologies of fever in severe
BSI is challenging, first, because of lack of affordable diagnostic
tools for conditions other than malaria, and second, fever is a
non-specific symptom due to a panoply of conditions. This study
demonstrated etiologies of severe febrile illness in 20% of children
hospitalized in Dar es Salaam, Tanzania.
The frequent use of antibiotics before specimen for blood
culture is taken can likely underestimate the incidence of BSI,
especially for fastidious bacteria such as pneumococci, which are
susceptible to commonly used antibiotics. In the present study,
over three quarters of the children received antibiotics prior
to blood culture. This is important to take into account when
estimating the relative importance of different infectious agents
in severe infections in children. Nevertheless, the prevalence of
bacteraemia and fungemia obtained in this study is comparable
to what was reported in children in Dar es Salaam (14%) 17 years
ago (Blomberg et al., 2007) and in other low- and middle-income
countries (11%) (Prasad et al., 2015). As previously reported
(Blomberg et al., 2007), K. pneumoniae and E. coli were the most
common bacteria isolated.
Dar es Salaam is the region of low to moderate malaria
endemicity (Wang et al., 2006; D’Acremont et al., 2011). Despite
using a very sensitive molecular method (Hofmann et al., 2015),
our study found a low prevalence of malaria (10%) compared to
22% in the year 2001/2002 and 25% in 2009 using microscopy and
PCR, respectively, in previous studies among children admitted
with febrile illness in the Dar es Salaam region (Blomberg et al.,
2005; Strom et al., 2013). The observed low malaria prevalence
in this study provide further evidence of the potential benefits of
national malaria control strategies in reducing malaria cases in
Tanzania and elsewhere in sub-Saharan Africa (Mtove et al., 2011;
Bhatt et al., 2015). Although some studies (Mackenzie et al., 2010;
Mtove et al., 2011; Scott et al., 2011) have found that reduction
of malaria cases occurs in parallel with reduction of invasive
bacteria in BSI in children, our findings of the same prevalence
of bacteraemia in Dar es Salaam as many years back, does not
support such parallel decline. This may partly be explained by the
finding that malaria has been associated with bacteraemia caused
by non-typhoid Salmonella (Takem et al., 2014), which is not
common in the present study setting.
We found significant association between the quantity of
P. falciparum genomes in blood and the most severe form of
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TABLE 3 | Risk factors for in-hospital death among children admitted with fever
from March 2017 to July 2018 in Dar es Salaam, Tanzania.
Demographic/clinical characteristics Death Multivariable analysis
n = 1,988
n (%) P-value; OR (95% CI)
Age of the child in months
0–3 (n = 1185) 43 (3.6) 0.13; 1.98 (0.82–4.80)
4–6 (n = 113) 6 (5.3) 0.16; 2.40 (0.70–8.22)
7–11 (n = 212) 13 (6.1) 0.29; 1.69 (0.63–4.56)
12–24 (n = 284) 15 (5.3) 0.21; 1.83 (0.71–4.70)
≥25 (n = 352) 12 (3.4) 1
Sex
Female (n = 898) 40 (4.5) 0.59; 1.15 (0.69–1.89)
Male (n = 1,248) 49 (3.9) 1
Study site
Mwananyamala (n = 236) 1 (0.4) 1
MNH (n = 220) 25 (11.4) 0.003; 20.99 (2.72–161.85)
Amana (n = 751) 21 (2.8) 0.28; 3.19 (0.39–26.22)
Temeke (n = 939) 42 (4.5) 0.09; 5.97 (0.78–46.02)
Malaria
Positive (n = 194) 4 (2.1) 0.02; 0.25 (0.08–0.79)
Negative (n = 1,794) 74 (4.1) 1
Bacteraemia/fungaemia
Positive (n = 227) 18 (7.9) 0.03; 2.04 (1.09–3.83)
Negative (n = 1,919) 71 (3.7) 1
Convulsions
Yes (n = 315) 33 (10.5) 0.74; 0.89 (0.44–1.79)
No (n = 1,831) 56 (3.1) 1
Consciousness
Unconscious (n = 122) 39 (32.0) <0.001; 25.54 (12.07–54.01)
Awake (n = 1,543) 37 (2.4) 1
Jaundice
Yes (n = 60) 7 (11.7) 0.49; 1.47 (0.49–4.43)
No (n = 2086) 82 (3.9) 1
OR, odds ratio; CI, confidence interval; confidence intervals that do not overlap the
null value of OR = 1 are shown in bold.
clinical malaria with three or more severity criteria. This concurs
with the findings of a multicenter study by Imwong et al. (2015).
The findings of this study and that of Imwong et al. (2015) suggest
that the use of plasma qPCR could help to differentiate severe
from non-severe malaria, and if possible, guide management
of severe BSI caused by malaria. In addition, 40% of children
with malaria-bacteria co-infection had severe malaria, as well as
high parasite load of P. falciparum in plasma. These findings
agree with that of Berkley et al. (2009) and Nadjm et al. (2010)
who have previously reported association between high malaria
parasitaemia and bacterial co-infection.
We report a high rate of AMR among Gram-negative
bacteria, which is in agreement with previous findings (Blomberg
et al., 2007). In addition, we found a significant increase
of ESBL producing Gram-negative bacteria (50.7%) compared
to a previous study (15%, P < 0.001) in the same study
setting (Blomberg et al., 2005). Most bacteria were MDR,
leaving limited treatment options available. The frequent
use of antibiotics including third generation cephalosporins
following empirical treatment guideline might have promoted an
increase in antimicrobial resistance. It is worrisome that among
K. pneumoniae, which is the commonest cause of BSI, 90% are
ESBL producers as well as being resistant to gentamicin. This
means that penicillins, cephalosporins, and aminoglycosides,
which are the most frequently used drugs for the treatment of
BSI, are inappropriate. The finding of high in-hospital death of
Klebsiella bloodstream infection in our study supports previous
findings (Zaidi et al., 2005; Blomberg et al., 2007).
The majority of children (89%) who received antibiotics
on admission did not have growth in blood culture. A high
proportion of children were given an antibiotic on admission
because the study setting is a low-income country, and availability
of laboratory tests such as blood culture to confirm for the
bacterial etiology of fever is limited to a few referral hospitals. As
a result, initial use of antibiotics following empirical treatment
guidelines by the clinicians is difficult to avoid, in an attempt
to save lives of children with life threatening severe BSI. This
massive use of antibiotics will contribute to increase the existing
problem of antimicrobial resistance in this study setting.
In the present study the in-hospital mortality was 4%. This
is much lower than was reported 17 years ago by Blomberg
et al. (2007) (34.9%) in the same city. One reason for such as
big difference could be that the previous study included only
children admitted to the tertiary hospital (MNH), indicating
that patients were severely ill and likely were referred late from
other hospitals. In the present study the majority of children
were included from regional hospitals, and a minority from the
referral national hospital. Even in the present study, children
admitted at the tertiary level hospital had a higher risk of death
than children admitted to lower level hospitals. Other reasons
for low in-hospital death could be a general reduction in under-
five mortality attributed to expanded malaria control programs
including availability of effective malaria treatment drugs such
as ACTs in Tanzania (Smithson et al., 2015). Furthermore,
the pneumococcal vaccination program and a reduction in
HIV transmission may also have contributed to the reduction
in under-five mortality. In-hospital mortality was significantly
higher among bacteraemic children compared to children with
malaria. This is in agreement with previous findings in Tanzania
and Kenya and implies that survival of children with BSI requires
prompt antimicrobial treatment (Berkley et al., 2005; Blomberg
et al., 2007). In the present study, only four children with malaria
died and three of these children received appropriate anti-
malarial treatment. These children may have died because they
presented too late at the hospital, they were unconscious, which
was found as an independent risk factor for death in the study,
and as a result they could not benefit from the malaria treatment
they received. Bacteraemia was an independent risk factor for
in-hospital mortality, as previously reported (Blomberg et al.,
2005; Bassat et al., 2009; Nadjm et al., 2010). Furthermore, over
two thirds of bacteraemic children who died were infected with
Gram-negative bacteria, concurrent with other studies (Blomberg
et al., 2007). Sixteen out of 18 (88%) of the children died with
bacteraemia despite receiving antibiotics. This could be because
most of the bacteria isolated were resistant to given regimens, and
treatment they received was thus inappropriate.
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This study has some limitations. First, our study was able
to identify etiologies of severe febrile illness for only 20% of
participants, because viruses and zoonotic bacteria were not
investigated for in this study. Viruses were found to be the most
common cause of fever in children attending outpatient clinics
in Dar es Salaam (D’Acremont et al., 2011). Whether this is also
the case in admitted children requires further analysis. In a study
from the northern part of Tanzania, many children admitted with
fever had zoonotic infections such as leptospirosis, brucellosis,
Q-fever, and rickettsiosis (Crump et al., 2013). Second, diagnosis
of BSI due to specific syndromes such as pneumonia, meningitis,
UTI, gastroenteritis, and upper respiratory tract infections, which
would require analysis of additional specimens such as CSF, urine,
sputum culture, chest x-ray, and nasopharyngeal swabs, was not
performed in this study. Third, we found that HIV infection
increased risk of in-hospital death in the univariable analysis.
However, the missing data on HIV results made it impossible for
HIV variable to be included in multivariable analysis, and hence
we could not confirm or rule out HIV infection as a cause of in-
hospital death. HIV-DNA PCR was not performed to confirm the
rapid HIV antibody test for infants below 18 months. Last, we
did not have outcomes of 80 children whose results may have
changed the fatality data presented.
In summary, compared to previous studies in this region,
our study showed a reduction in malaria prevalence, a decrease
in in-hospital mortality, and an increase in antimicrobial
resistance (AMR) including ESBLs and multidrug resistance.
A decrease in mortality may be attributed to the on-going
implemented malaria control programs in the country, and the
implementation of artemisinin-based treatment regimens may
also have contributed. A reduction of congenital HIV may
also have contributed to the reduced mortality. An increase of
AMR highlights the importance of continued strengthening of
diagnostic capability and antimicrobial stewardship programs.
We also found malaria and bacteraemia contributed equally in
causing febrile illness, but bacteraemia caused higher in-hospital
death. The most severe form of clinical malaria was associated
with P. falciparum parasitaemia.
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